RACHELL BREGANT: Open Payments
NPI 1528148343 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$371 in 4 payments from 3 companies in 2025. Trend: 2023 $120 · 2024 $287 · 2025 $371
Food & beverage: $371
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $236 |
| Lilly USA, LLC | 1 | $114 |
| Novo Nordisk Inc | 1 | $21 |
Products named: FARXIGA, ZEPBOUND, AIRSUPRA.
Industry payments across VA — which companies pay providers there.
